To evaluate whether the postulated prediction of sensitivity to GWL inhibition has any clinical significance, we assessed RNA expression profiles of GWL and B55α in biopsies from normal and cancer tissues obtained from the Cancer Genome Atlas (TCGA) repository, generated by the TCGA Research Network (Fig. 8a, b). The gene discussed is MASTL; the disease is cancer.